SBFM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sunshine Biopharma Inc (SBFM) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of strong technical indicators, and no recent positive news or catalysts make this stock a hold rather than a buy.
The technical indicators show a bearish trend. The MACD is below 0 and negatively contracting, the RSI is neutral at 28.595, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 1.013, but there is no strong signal for a reversal.
Hedge funds are significantly increasing their buying activity, with a 11812.88% increase over the last quarter.
The company's financial performance is weak, with a YoY drop in net income (-26.21%), EPS (-79.79%), and gross margin (-4.79%). No recent news or significant insider trading trends have been reported.
In Q3 2025, revenue increased by 11.64% YoY to $9,417,179. However, net income dropped to -$883,820 (-26.21% YoY), EPS fell to -0.19 (-79.79% YoY), and gross margin declined to 31.62% (-4.79% YoY).
No recent analyst ratings or price target changes are available.
